Trends in genetic patent applications: The commercialization of academic intellectual property

J.G. Kers, J.C. van Burg, T. Stoop, M.C. Cornel

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

We studied trends in genetic patent applications in order to identify the trends in the commercialization of research findings in genetics. To define genetic patent applications, the European version (ECLA) of the International Patent Classification (IPC) codes was used. Genetic patent applications data from the PATSTAT database from 1990 until 2009 were analyzed for time trends and regional distribution. Overall, the number of patent applications has been growing. In 2009, 152 000 patent applications were submitted under the Patent Cooperation Treaty (PCT) and within the EP (European Patent) system of the European Patent Office (EPO). The number of genetic patent applications increased until a peak was reached in the year 2000, with >8000 applications, after which it declined by almost 50%. Continents show different patterns over time, with the global peak in 2000 mainly explained by the USA and Europe, while Asia shows a stable number of >1000 per year. Nine countries together account for 98.9% of the total number of genetic patent applications. In The Netherlands, 26.7% of the genetic patent applications originate from public research institutions. After the year 2000, the number of genetic patent applications dropped significantly. Academic leadership and policy as well as patent regulations seem to have an important role in the trend differences. The ongoing investment in genetic research in the past decade is not reflected by an increase of patent applications.
LanguageEnglish
Pages1155-1159
Number of pages5
JournalEuropean Journal of Human Genetics
Volume22
Early online date22 Jan 2014
DOIs
Publication statusPublished - 2014

Fingerprint

Intellectual Property
Technology Transfer
International Cooperation
Genetic Research
Netherlands
Databases
Research

Cite this

@article{1ab889701b994ab0aedd5be701b6cd8c,
title = "Trends in genetic patent applications: The commercialization of academic intellectual property",
abstract = "We studied trends in genetic patent applications in order to identify the trends in the commercialization of research findings in genetics. To define genetic patent applications, the European version (ECLA) of the International Patent Classification (IPC) codes was used. Genetic patent applications data from the PATSTAT database from 1990 until 2009 were analyzed for time trends and regional distribution. Overall, the number of patent applications has been growing. In 2009, 152 000 patent applications were submitted under the Patent Cooperation Treaty (PCT) and within the EP (European Patent) system of the European Patent Office (EPO). The number of genetic patent applications increased until a peak was reached in the year 2000, with >8000 applications, after which it declined by almost 50{\%}. Continents show different patterns over time, with the global peak in 2000 mainly explained by the USA and Europe, while Asia shows a stable number of >1000 per year. Nine countries together account for 98.9{\%} of the total number of genetic patent applications. In The Netherlands, 26.7{\%} of the genetic patent applications originate from public research institutions. After the year 2000, the number of genetic patent applications dropped significantly. Academic leadership and policy as well as patent regulations seem to have an important role in the trend differences. The ongoing investment in genetic research in the past decade is not reflected by an increase of patent applications.",
author = "J.G. Kers and {van Burg}, J.C. and T. Stoop and M.C. Cornel",
year = "2014",
doi = "10.1038/ejhg.2013.305",
language = "English",
volume = "22",
pages = "1155--1159",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",

}

Trends in genetic patent applications: The commercialization of academic intellectual property. / Kers, J.G.; van Burg, J.C.; Stoop, T.; Cornel, M.C.

In: European Journal of Human Genetics, Vol. 22, 2014, p. 1155-1159.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Trends in genetic patent applications: The commercialization of academic intellectual property

AU - Kers, J.G.

AU - van Burg, J.C.

AU - Stoop, T.

AU - Cornel, M.C.

PY - 2014

Y1 - 2014

N2 - We studied trends in genetic patent applications in order to identify the trends in the commercialization of research findings in genetics. To define genetic patent applications, the European version (ECLA) of the International Patent Classification (IPC) codes was used. Genetic patent applications data from the PATSTAT database from 1990 until 2009 were analyzed for time trends and regional distribution. Overall, the number of patent applications has been growing. In 2009, 152 000 patent applications were submitted under the Patent Cooperation Treaty (PCT) and within the EP (European Patent) system of the European Patent Office (EPO). The number of genetic patent applications increased until a peak was reached in the year 2000, with >8000 applications, after which it declined by almost 50%. Continents show different patterns over time, with the global peak in 2000 mainly explained by the USA and Europe, while Asia shows a stable number of >1000 per year. Nine countries together account for 98.9% of the total number of genetic patent applications. In The Netherlands, 26.7% of the genetic patent applications originate from public research institutions. After the year 2000, the number of genetic patent applications dropped significantly. Academic leadership and policy as well as patent regulations seem to have an important role in the trend differences. The ongoing investment in genetic research in the past decade is not reflected by an increase of patent applications.

AB - We studied trends in genetic patent applications in order to identify the trends in the commercialization of research findings in genetics. To define genetic patent applications, the European version (ECLA) of the International Patent Classification (IPC) codes was used. Genetic patent applications data from the PATSTAT database from 1990 until 2009 were analyzed for time trends and regional distribution. Overall, the number of patent applications has been growing. In 2009, 152 000 patent applications were submitted under the Patent Cooperation Treaty (PCT) and within the EP (European Patent) system of the European Patent Office (EPO). The number of genetic patent applications increased until a peak was reached in the year 2000, with >8000 applications, after which it declined by almost 50%. Continents show different patterns over time, with the global peak in 2000 mainly explained by the USA and Europe, while Asia shows a stable number of >1000 per year. Nine countries together account for 98.9% of the total number of genetic patent applications. In The Netherlands, 26.7% of the genetic patent applications originate from public research institutions. After the year 2000, the number of genetic patent applications dropped significantly. Academic leadership and policy as well as patent regulations seem to have an important role in the trend differences. The ongoing investment in genetic research in the past decade is not reflected by an increase of patent applications.

U2 - 10.1038/ejhg.2013.305

DO - 10.1038/ejhg.2013.305

M3 - Article

VL - 22

SP - 1155

EP - 1159

JO - European Journal of Human Genetics

T2 - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

ER -